SCIENTURE HOLDINGS, INC. Contract Liability (Deferred Revenue)
SCIENTURE HOLDINGS, INC. (SCNX) had Contract Liability (Deferred Revenue) of $996 as of 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2022-05-09
- 2022-03-31: Contract with Customer, Liability, Current $996.00.
- 2021-03-31: Contract with Customer, Liability, Current $10.00K.
- 2020-12-31: Contract with Customer, Liability, Current $10.00K.
- 2020-06-30: Contract with Customer, Liability, Current $3.57K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2022-03-31 | $996.00 10-Q · filed 2022-05-09 |
| 2021-03-31 | $10.00K 10-Q · filed 2021-04-26 |
| 2020-12-31 | $10.00K 10-K · filed 2022-03-28 |
| 2020-06-30 | $3.57K 10-Q · filed 2020-07-27 |
| 2020-03-31 | $305.97K 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |